Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00123604 · ClinicalTrials.gov registry record · Phase 4
Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes
A Phase 4 study, sponsored by St. Paul Heart Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
NCT00123604 is a Phase 4 study that has completed, run by St. Paul Heart Clinic. The registered enrollment target is 36 participants.
The verdict
NCT00123604, a Phase 4 study, has completed, sponsored by St. Paul Heart Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the vascular effects of two commonly used blood pressure medications, carvedilol and metoprolol in hypertensive patients with type 2 diabetes.
Interventions
- DRUG Carvedilol
- DRUG Metoprolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2004-06 |
| Est. Completion | 2006-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00123604
The ClinicalTrials.gov registry entry for NCT00123604 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Paul Heart Clinic, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Carvedilol is the first listed.
NCT00123604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00123604 about?
NCT00123604 is a clinical study titled "Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes". The purpose of this study is to compare the vascular effects of two commonly used blood pressure medications, carvedilol and metoprolol in hypertensive patients with type 2 diabetes.
What is the current status of trial NCT00123604?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2004-06. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00123604?
The interventions under investigation include: Carvedilol (DRUG), Metoprolol (DRUG).
Who is sponsoring clinical trial NCT00123604?
This trial is sponsored by St. Paul Heart Clinic, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.